Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is the evaluate the safety and tolerability of AZD5069 in patients with Chronic Obstructive Pulmonary Disease


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01233232
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 2
Start date November 2010
Completion date March 2011